Benefit of EGFR-inhibition therapy for metastatic colorectal cancer patients with KRAS-mutated tumors and high plasma TIMP-1 level: Results from the NORDIC VII study.
Nils Brunner
No relevant relationships to disclose
Line Schmidt Tarpgaard
No relevant relationships to disclose
Ib Jarle Christensen
No relevant relationships to disclose
Jose Moreira
No relevant relationships to disclose
Tormod Kyrre Guren
No relevant relationships to disclose
Bengt Glimelius
No relevant relationships to disclose
Halfdan Sorby
No relevant relationships to disclose
Tone Ikdahl
No relevant relationships to disclose
Elin Kure
No relevant relationships to disclose
Kjell Magne Tveit
No relevant relationships to disclose
Hans Jørgen Nielsen
No relevant relationships to disclose
Per Pfeiffer
No relevant relationships to disclose